Connecting Regions of Asia.

Bangladesh Company Hopes Its Antiviral Drug Will Help Tackle Covid


Bangladesh’s Beximco Pharma claimed to have become the world’s first company to start selling the generic version of Gilead Sciences Inc.’s antiviral drug that may help tackle the deadly coronavirus pandemic.
The Dhaka-based Beximco, which counts Norges Bank as one of its investors, will sell remdesivir for about 6,000 taka ($71) a vial to private clinics .
But Beximco COO Rabbur Reza told Eastertnlink that they  will give it free to state-run hospitals treating Covid-19 patients. A critically ill Covid-19 patient will need at least six vials, he said.
Bangladesh can produce generic versions of patented drugs under World Trade Organization provisions that grant least developed countries a waiver from seeking licenses. 
Remdesivir was cleared by U.S. drug regulator for emergency use in Covid-19 patients, becoming the first medication backed by early clinical data to be made available to fight the novel pathogen.

Get real time updates directly on you device, subscribe now.

Leave A Reply

Your email address will not be published.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More